International Consensus on Use of Continuous Glucose Monitoring

Danne, Thomas, Nimri, Revital, Battelino, Tadej, Bergenstal, Richard M., Close, Kelly L., DeVries, J. Hans, Garg, Satish, Heinemann, Lutz, Hirsch, Irl, Amiel, Stephanie A., Beck, Roy, Bosi, Emanuele, Buckingham, Bruce, Cobelli, Claudio, Dassau, Eyal, Doyle, Francis J., Heller, Simon, Hovorka, Roman, Jia, Weiping, Jones, Tim, Kordonouri, Olga, Kovatchev, Boris, Kowalski, Aaron, Laffel, Lori, Maahs, David, Murphy, Helen R., Nørgaard, Kirsten, Parkin, Christopher G., Renard, Eric, Saboo, Banshi, Scharf, Mauro, Tamborlane, William V., Weinzimer, Stuart A., Phillip, Moshe·2017·Diabetes Care
DOI 10.2337/dc17-1600

Cited by (1,003)

Items 501–600 of 1,003

  1. Continuous noninvasive glucose monitoring; water as a relevant marker of glucose uptake in vivo
    Andreas Caduff, Paul Ben Ishai, Yuri D. Feldman · 2019 · Biophysical Reviews
  2. GLU: a software package for analysing continuously measured glucose levels in epidemiology
    Louise A C Millard, Nashita Patel, Kate M. Tilling, Melanie Lewcock, Peter A. Flach, Debbie A. Lawlor · 2020 · International Journal of Epidemiology
  3. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy – Pump vs multiple daily injections, a secondary analysis of an observational cohort study
    Karin Kjölhede, Kerstin E. Berntorp, Karl Heby Kristensen, Anastasia Katsarou, Nael Shaat, Nana Wiberg, Filip Krag Knop, Lars Kristensen, Annika Dotevall, Anders Elfvin et al. · 2020 · Acta Obstetricia Et Gynecologica Scandinavica
  4. Association of specialized enteral nutrition with glycemic control and clinical outcomes in critically ill patients: A meta-analysis of randomized controlled trials
    Igor da Conceição Eckert, Magali C.C. Kumbier, Flávia Moraes Silva, Oellen Stuani Franzosi, Jussara Carnevale de Almeida · 2021 · Clinical Nutrition
  5. Hypoglycemia prevention: PID-type controller adaptation for glucose rate limiting in Artificial Pancreas System
    Nicolás Rosales, Hernán De Battista, Fabricio Garelli · 2021 · Biomedical Signal Processing and Control
  6. Recent advances in closed-loop insulin delivery
    Julia Ware, Roman Hovorka · 2021 · Metabolism
  7. Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease
    Philippe Oriot, Claire Viry, Antoine Vandelaer, S. Grigioni, Malanie Roy, Jean‐Christophe Philips, Gaëtan Prévost · 2022 · Journal of Diabetes Science and Technology
  8. Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration
    Halis Kaan Aktürk, Pau Herrero, Nick S. Oliver, Haley Wise, Emma Eikermann, Janet K. Snell‐Bergeon, Viral N. Shah · 2022 · Diabetes Technology & Therapeutics
  9. Technology in the Management of Type 1 and Type 2 Diabetes Mellitus: Recent Status and Future Prospects
    Titas Biswas, Biplab Kumar Behera, Nithar Ranjan Madhu · 2023 · Springer eBooks
  10. Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability
    Vadim Valer'evich Klimontov, Kamilla R. Mavlianova, Н. Б. Орлов, Julia F. Semenova, Anton Ivanovich Korbut · 2023 · Biomedicines
  11. Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy
    Agnes Sola‐Gazagnes, Pauline Faucher, Sophie Jacqueminet, Cécile Ciangura, Danièle Dubois‐Laforgue, Helen Mosnier-Pudar, Ronan Roussel, Étienne Larger · 2019 · Diabetes & Metabolism
  12. Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care
    Jeff Unger, Pamela R. Kushner, John E. Anderson · 2020 · Postgraduate Medicine
  13. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
    Lutz Heinemann, Guido Freckmann, Dirk Müller‐Wieland, Monika Kellerer · 2019 · Journal of Diabetes Science and Technology
  14. Efficacy of hybrid closed-loop system in adults with type 1 diabetes and gastroparesis
    Kaur, Harsahiba, Schneider, Nicole, Pyle, Laura, Campbell, Kristen, Akturk, Halis K., Shah, Viral N. · 2019 · Diabetes Technology & Therapeutics
  15. Continuous glucose monitoring versus self-monitoring of blood glucose in the management of cystic fibrosis related diabetes: a systematic review and meta-analysis
    Kumar, Shanal, Soldatos, Georgia, Ranasinha, Sanjeeva, Teede, Helena, Pallin, Michael · 2023 · Journal of Cystic Fibrosis
  16. Beyond HbA1c: using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision‐making
    Brown, S. A., Basu, A., Kovatchev, B. P. · 2019 · Diabetic Medicine
  17. Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study
    Tara Lee, Corinne Collett, Simon Bergford, Sara Hartnell, ELEANOR M. SCOTT, Robert S. Lindsay, Katharine F. Hunt, David R. McCance, Rebecca M. Reynolds, Malgorzata E. Wilinska et al. · 2025 · The Lancet Diabetes & Endocrinology
  18. Future horizons in diabetes: integrating AI and personalized care
    Kaiqi Zhang, Yun Peng Qi, Wenjun Wang, Xinyi Tian, Jiahui Wang, Lili Xu, Xu Zhai · 2025 · Frontiers in Endocrinology
  19. Performance of three different continuous glucose monitoring systems in children with type 1 diabetes during a diabetes summer camp
    Katrin Nagl, Gabriele Berger, Felix Aberer, Haris Ziko, Katharina Weimann, Ina Bozic, Birgit M. Rami-Merhar, Julia Katharina Mader · 2020 · Pediatric Diabetes
  20. Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes
    Qingyu Guo, Bin Lu, Zhanhong Guo, Zhouqin Feng, Yanyu Yuan, Xuguang Jin, Pu Zang, Ping Gu, Jiaqing Shao · 2020 · World Journal of Diabetes
  21. A Digital Health Intervention (SweetGoals) for Young Adults With Type 1 Diabetes: Protocol for a Factorial Randomized Trial
    Catherine Stanger, Tobias Kowatsch, Haiyi Xie, Inbal Billie Nahum-Shani, Frances Lim-Liberty, Molly A. B. Anderson, Prabhakaran Santhanam, Sarah J. Kaden, Briana Rosenberg · 2021 · JMIR Research Protocols
  22. Continuous Glucose Monitoring (CGM) Is a Tool, Not a Reward: Unjustified Insurance Coverage Criteria Limit Access to CGM
    Davida F. Kruger, John E. Anderson · 2021 · Diabetes Technology & Therapeutics
  23. In Vivo Monitoring of Glucose Using Ultrasound-Induced Resonance in Implantable Smart Hydrogel Microstructures
    Navid Farhoudi, Lars B. Laurentius, Jules John Magda, Christopher F. Reiche, Florian Solzbacher · 2021 · ACS Sensors
  24. Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes
    Rafał Sibiak, Paweł Gutaj, Beata Mrzewka-Rogacz, Urszula Mantaj, Ewa Wender-Ożegowska · 2021 · Diabetes Technology & Therapeutics
  25. Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia
    Jothydev Kesavadev, Anoop Misra, Banshi Saboo, Sanjay Agarwal, Aravind Sosale, Shashank Joshi, Akhtar Hussain, Noel Pratheepan Somasundaram, Abdul Basit, Pratik Choudhary et al. · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  26. A head‐to‐head comparison between Guardian Connect and FreeStyle Libre systems and an evaluation of user acceptability of sensors in patients with type 1 diabetes
    Ester Chai Kheng Yeoh, Doanna Png, Jonathon Khoo, Ying Jie Chee, Puja Sharda, Serena KM Low, Su Chi Lim, Tavintharan Subramaniam · 2022 · Diabetes/Metabolism Research and Reviews
  27. Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study
    Kirsten Nørgaard, Ajenthen Gayathri Ranjan, Christian Laugesen, Katrine G Tidemand, Allan Green, Christian Selmer, Jannet Svensson, Henrik Ullits Andersen, Dorte Vistisen, Bendix Carstensen · 2023 · Diabetes Care
  28. Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics
    Paloma Pérez-López, Pablo Fernández-Velasco, Pilar Bahillo-Curieses, Daniel Antonio de Luis, Gonzalo Díaz-Soto · 2023 · Endocrine
  29. Breakfast replacement with a liquid formula improves glycaemic variability in patients with type 2 diabetes: a randomised clinical trial
    Jiahui Peng, Jingyi Lu, Xiaojing Ma, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Jian Zhou · 2018 · British Journal Of Nutrition
  30. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
    EMMA S. SCOTT, Rachel Therese McGrath, Andrzej S. Januszewski, Daniel Calandro, Anandwardhan A. Hardikar, David Norman O'Neal, Gregory R. Fulcher, Alicia Josephine Jenkins · 2019 · BMJ Open
  31. Utilizing continuous glucose monitoring in primary care practice: What the numbers mean
    Steven V. Edelman, Tricia Santos Cavaiola, SCHAFER C. BOEDER, Jeremy Pettus · 2020 · Primary care diabetes
  32. Artificial Pancreas: In Silico Study Shows No Need of Meal Announcement and Improved Time in Range of Glucose With Intraperitoneal vs. Subcutaneous Insulin Delivery
    Toffanin, Chiara, Magni, Lalo, Cobelli, Claudio · 2021 · IEEE Transactions on Medical Robotics and Bionics
  33. InRange: Comparison of the second-generation basal insulin analogues glargine 300 u/ml and degludec 100 u/ml in persons with type 1 diabetes using continuous glucose monitoring-study design
    Battelino, Tadej, Bosnyak, Zsolt, Danne, Thomas, Mukherjee, Bhaswati, Edelman, Steve, Pilorget, Valerie, Choudhary, Pratik, Renard, Eric, Bergenstal, Richard · 2020 · Diabetes Therapy
  34. Health Care Costs, Hospital Admissions, and Glycemic Control Using a Standalone, Real-Time, Continuous Glucose Monitoring System in Commercially Insured Patients With Type 1 Diabetes
    Max Gill, Cyrus Zhu, Mona Shah, Harmeet Chhabra · 2018 · Journal of Diabetes Science and Technology
  35. Chinese clinical guidelines for continuous glucose monitoring (2018 edition)
    Yuqian Bao, Li Chen, Liming Chen, Jingtao Dou, Zhengnan Gao, Leili Gao, Lixin Guo, Xiaohui Guo, Linong Ji, Qiuhe Ji et al. · 2019 · Diabetes/Metabolism Research and Reviews
  36. Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12‐week randomized controlled trial
    André Gustavo Daher Vianna, Claudio Silva de Lacerda, Luciana Muniz Pechmann, Michelle Garcia Polesel, Emerson Cestari Marino, Mauro Scharf, Josiane M. Detsch, Kleber Marques, Claudia P. Sanches · 2019 · Diabetes Obesity and Metabolism
  37. Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring
    Caroline Trunk‐Black Juel, Thomas Fremming Dejgaard, Carsten Palnæs Hansen, Jan Henrik Storkholm, Tina Vilsbøll, Asger Lund, Filip Krag Knop · 2020 · The Journal of Clinical Endocrinology & Metabolism
  38. Symbolic Control Design of an Artificial Pancreas for Type-2 Diabetes
    Alessandro Borri, Giordano Pola, Pierdomenico Pepe, Maria Domenica Di Benedetto, Pasquale J Palumbo · 2021 · IEEE Transactions on Control Systems Technology
  39. Glycaemic Variability and Hyperglycaemia as Prognostic Markers of Major Cardiovascular Events in Diabetic Patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart Failure
    Édouard Gerbaud, Ambroise Bouchard de la Poterie, Thomas Baudinet, Michel Montaudon, Marie-Christine Beauvieux, Anne-Iris Lemaître, Laura Cetran, Benjamin Séguy, Francois Picard, Fritz-Line Vélayoudom et al. · 2022 · Journal of Clinical Medicine
  40. Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients
    Yaxin Wang, Jingyi Lu, Yun Shen, Jiaying Ni, Lei Zhang, Wei Lu, Wei Zhu, Yuqian Bao, Jian Zhou · 2022 · Journal of Diabetes Investigation
  41. Closed-Loop Insulin Delivery Effects on Glycemia During Sleep and Sleep Quality in Older Adults with Type 1 Diabetes: Results from the ORACL Trial
    Anindita Chakrabarti, Steven L. Trawley, Erin Kubilay, Andisheh Mohammad Alipoor, Sara Vogrin, Spiros Fourlanos, Melissa H. Lee, David Norman O'Neal, Niamh O’Regan, Vijaya Sundararajan et al. · 2022 · Diabetes Technology & Therapeutics
  42. Diabetic neuropathy: Past, present, and future.
    Juan Eduardo Quiroz Aldave, María del Carmen Durand‐Vásquez, Elman Rolando Gamarra Osorio, Jacsel Suárez-Rojas, Pela Jantine Roseboom, Rosa María Alcalá‐Mendoza, Julia Arroyo, Francisca Elena Zavaleta‐Gutiérrez, Luis Alberto Concepción Urteaga, Marcio José Concepción‐Zavaleta · 2023 · PubMed Central
  43. Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single‐centre real‐world study
    Elif Eviz, Nesrin Ecem Kıllı, Kagan Ege Karakus, Ecem Can, Tuğba Gökçe, Gül Yeşiltepe Mutlu, Şükrü Hatun · 2024 · Diabetic Medicine
  44. Closed-loop insulin delivery: current status of diabetes technologies and future prospects
    Waseem Majeed, Hood Thabit · 2018 · Expert Review of Medical Devices
  45. The correlation between glucose fluctuation from self-monitored blood glucose and the major adverse cardiac events in diabetic patients with acute coronary syndrome during a 6-month follow-up by WeChat application
    Jinggang Xia, Shaodong Hu, Ji Xu, Hengjian Hao, Chunlin Yin, Dong Xu · 2018 · Clinical Chemistry and Laboratory Medicine (CCLM)
  46. Targets for blood glucose: What have the trials told us
    Paul Elie Valensi, Gaëtan Prévost, Oliver Schnell, Eberhard Standl, Antonio Ceriello · 2019 · European Journal of Preventive Cardiology
  47. Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes
    Marie Mathilde Bjerg Christensen, Eva Elisabeth Hommel, Marit E. Jørgensen, Jesper Fleischer, Christian Stevns Hansen · 2020 · Frontiers in Endocrinology
  48. Associations of Time in Range and Other Continuous Glucose Monitoring–Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends
    Dominic Ehrmann, Lilli Priesterroth, ANDREAS J. SCHMITT, Bernhard Kulzer, Norbert Hermanns · 2021 · Diabetes Spectrum
  49. Hypoglycaemia and its management in primary care setting
    Ibrahim, Mahmoud, Baker, Jason, Cahn, Avivit, Eckel, Robert H., El Sayed, Nuha Ali, Fischl, Amy Hess, Gaede, Peter, Leslie, R. David, Pieralice, Silvia, Tuccinardi, Dario et al. · 2020 · Diabetes/Metabolism Research and Reviews
  50. Time in range—A new gold standard in type 2 diabetes research?
    Ashni Goshrani, Rose Lin, David Norman O'Neal, Elif Ilhan Ekinci · 2025 · Diabetes Obesity and Metabolism
  51. American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes – 2026 Update
    Susan Leanne Samson, Priyathama Vellanki, Lawrence Blonde, Irl B. Hirsch, Thanh D. Hoang, Scott D. Isaacs, Kenneth E. Izuora, Cecilia C. Low Wang, Cheow Peng Ooi, Blanca Iris Padilla et al. · 2026 · Endocrine Practice
  52. Continuous glucose monitoring to assess glycemic control in the first 6 weeks after pancreas transplantation
    Vikash Dadlani, Ravinder Jeet Kaur, Mark D. Stegall, S Xyda, Kanchan Kumari, Keisha Bonner, Byron H. Smith, Prabin Bikram Thapa, Patrick G. Dean, Yogish C. Kudva · 2019 · Clinical Transplantation
  53. Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
    Sheyda Sofizadeh, Henrik Imberg, Arndís Finna Ólafsdóttir, Magnus Ekelund, Sofia Dahlqvist, Irl B. Hirsch, Karin Filipsson, Bo Åhrén, Stefan Sjöberg, Jaako Tuomilehto et al. · 2019 · Diabetes Therapy
  54. Current status of continuous glucose monitoring among Korean children and adolescents with type 1 diabetes mellitus
    Jae Hyun Kim · 2020 · Annals of Pediatric Endocrinology & Metabolism
  55. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring‐derived glycemic makers in children and adolescents with type 1 diabetes
    Junichi Suzuki, Tatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Ichiro Morioka · 2020 · Pediatrics International
  56. The effect of beta-glucan supplementation on glycemic control and variability in adolescents with type 1 diabetes mellitus
    Rukiye Bozbulut, Nevin Şanlıer, Esra Döğer, Aysun Bıdecı, Orhun M. Camurdan, Peyamı Cınaz · 2020 · Diabetes Research and Clinical Practice
  57. Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release
    Anna L. Krämer, Angelina Riederer, Federico Fracassi, Felicitas S. Boretti, Nadja S. Sieber‐Ruckstuhl, Thomas A. Lutz, Barbara Contiero, Eric Zini, Claudia E Reusch · 2020 · Journal of Veterinary Internal Medicine
  58. The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis
    Tobias Bomholt, Thomas Idorn, Filip Krag Knop, Morten Buus Jørgensen, Ajenthen Gayathri Ranjan, Marsela Resuli, Pernille May Hansen, Rikke Borg, Frederik Persson, Bo Feldt‐Rasmussen et al. · 2020 · The Nephron journals/Nephron journals
  59. Glycaemic Variability and Risk Factors of Pregnant Women with and without Gestational Diabetes Mellitus Measured by Continuous Glucose Monitoring
    Martina Gáborová, Viera Doničová, Ivana Bačová, Mária Pallayová, Martin Bona, Igor Peregrim, Sona Gresova, J. Stimmelova, Barbora Dzugasová, Lenka Šalamonová Blichová et al. · 2021 · International Journal of Environmental Research and Public Health
  60. Long-Term In Vivo Glucose Monitoring by Polymer-Dot Transducer in an Injectable Hydrogel Implant
    Jing Liu, Xiaofeng Fang, Zhe Zhang, Zhihe Liu, Jie Liu, Kai Sun, Zhen Yuan, Jiangbo Yu, Daniel T. Chiu, Changfeng Wu · 2022 · Analytical Chemistry
  61. Impact of Diabetes Duration on Functional and Clinical Status in Older Adults With Type 1 Diabetes
    Medha N. Munshi, Christine Slyne, Atif Adam, DAI’QUANN J. DAVIS, Amy Lynn Michals, Astrid Atakov-Castillo, Katie Weinger, Elena Toschi · 2022 · Diabetes Care
  62. Diet and Physical Activity as Determinants of Continuously Measured Glucose Levels in Persons at High Risk of Type 2 Diabetes
    Su Hyun Park, Jiali Yao, Xin Hui Chua, SURESH RAMA CHANDRAN, Daphne Su-Lyn Gardner, Chin Meng Khoo, Falk Müller‐Riemenschneider, Clare Whitton, Rob M. van Dam · 2022 · Nutrients
  63. A Personalized and Adaptive Insulin Bolus Calculator Based on Double Deep Q- Learning to Improve Type 1 Diabetes Management
    Giulia Noaro, Taiyu Zhu, Giacomo Cappon, Andrea Facchinetti, Pantelis Georgiou · 2023 · IEEE Journal of Biomedical and Health Informatics
  64. 24-Hour Movement Behaviours (Physical Activity, Sedentary Behaviour and Sleep) Association with Glycaemic Control and Psychosocial Outcomes in Adolescents with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Studies
    Mhairi Patience, Xanne Janssen, Alison F. Kirk, Stephanie McCrory, Eilidh Russell, William Hodgson, Megan M. Crawford · 2023 · International Journal of Environmental Research and Public Health
  65. Interrupting prolonged sitting with frequent short bouts of light‐intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: The SIT‐LESS randomised controlled trial
    Matthew D. Campbell, Anwar M. Alobaid, Mark Hopkins, Paddy C. Dempsey, Sam Matthew Pearson, Noppadol Kietsiriroje, Rachel Churm, Ramzi Ajjan · 2023 · Diabetes Obesity and Metabolism
  66. The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education
    Francesca De Ridder, Marieke den Brinker, Christophe E.M. De Block · 2019 · Therapeutic Advances in Endocrinology and Metabolism
  67. Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol
    Mingyue Zheng, Yunting Luo, Wei Lin, Adeel Akbar Khoja, Qian He, Shenqiao Yang, Xuan Zhao, Peng Hu · 2020 · Systematic Reviews
  68. Impacts of glycemic variability on the relationship between glucose management indicator from iPro ™ 2 and laboratory hemoglobin A1c in adult patients with type 1 diabetes mellitus
    Hongxia Liu, Daizhi Yang, Hongrong Deng, Wen Xu, Jing Lv, Yongwen Zhou, Sihui Luo, Xueying Zheng, Hua Liang, Bin Yao et al. · 2020 · Therapeutic Advances in Endocrinology and Metabolism
  69. Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function
    Guy Taylor, Kieran Smith, Tess E. Capper, Jadine H. Scragg, Ayat Bashir, Anneliese J. Flatt, Emma Stevenson, Timothy James McDonald, Richard A. Oram, James Shaw et al. · 2020 · Diabetes Care
  70. A head‐to‐head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot
    Othmar Moser, Marlene Pandis, Felix Aberer, Harald Kojzar, Daniel A. Hochfellner, Hesham Elsayed, Melanie Motschnig, Thomas Augustin, Philipp Kreuzer, Thomas Rudolf Pieber et al. · 2018 · Diabetes Obesity and Metabolism
  71. Machine Learning and Deep Learning Models for Nocturnal High- and Low-Glucose Prediction in Adults with Type 1 Diabetes
    Roman M. Kozinetz, Vladimir Berikov, Julia F. Semenova, Vadim Valer'evich Klimontov · 2024 · Diagnostics
  72. Current landscape and comprehensive management of glycemic variability in diabetic retinopathy
    Bo Chen, Chaozan Shen, Bao Sun · 2024 · Journal of Translational Medicine
  73. Challenges of Diabetes Care in Older People With Type 2 Diabetes and the Role of Basal Insulin
    Eugênio Cersósimo, Pearl Lee, Naushira Pandya · 2019 · Clinical Diabetes
  74. Disordered eating in women with type 1 diabetes: Continuous glucose monitoring reveals the complex interactions of glycaemia, self‐care behaviour and emotion
    SURESH RAMA CHANDRAN, Natalie Zaremba, Amy Harrison, Pratik Choudhary, Yee Cheah, Jacqueline Allan, Fredrik Debong, Fiona Reid, Janet L. Treasure, David Hopkins et al. · 2020 · Diabetic Medicine
  75. Beyond A1C—Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve
    Roy W. Beck, Richard M. Bergenstal · 2021 · Diabetes Spectrum
  76. Sensing Glucose Concentration Using Symmetric Metasurfaces under Oblique Incident Terahertz Waves
    Ibraheem A. I. Al-Naib · 2021 · Crystals
  77. Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes
    Charlotte S. Wilhelm-Benartzi, Sarah E. Miller, Sylvaine F. A. Bruggraber, Diane Picton, Mark Wilson, Katrina Gatley, Anita Chhabra, Maria Loredana Marcovecchio, Emile Hendriks, Hilde Morobé et al. · 2021 · BMJ Open
  78. ‘Much more convenient, just as effective’: Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis
    Molly L. Tanenbaum, Dessi P. Zaharieva, Ananta Addala, Priya Prahalad, Julie Hooper, Brianna Leverenz, Ana L. Cortes, Nora Arrizon‐Ruiz, Erica Pang, Franziska K. Bishop et al. · 2022 · Diabetic Medicine
  79. Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus
    Carlo Di Mario, Stefano Genovese, Gaetano Antonio Lanza, Edoardo Mannucci, Giancarlo Marenzi, Edoardo Sciatti, Dario Pitocco, the Expert Panel Group, Angelo Avogaro, Federico Bertuzzi et al. · 2022 · Cardiovascular Diabetology
  80. Assessment of the Glucose Management Indicator Using Different Sampling Durations
    Ryan J. Bailey, Peter M. Calhoun, Richard M. Bergenstal, Roy W. Beck · 2022 · Diabetes Technology & Therapeutics
  81. Recent Advances and Perspectives Regarding Paper-Based Sensors for Salivary Biomarker Detection
    Cong Chen, Lulu Tian, Wen Li, Kun Wang, Qijing Yang, Jinying Lin, Tianshou Zhang, Biao Dong, Lin Wang · 2023 · Chemosensors
  82. Insulin glargine/lixisenatide fixed‐ratio combination improves glycaemic variability and control without increasing hypoglycaemia
    Ronnie Aronson, Guillermo E. Umpierrez, William Stager, Boris P. Kovatchev · 2018 · Diabetes Obesity and Metabolism
  83. Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study
    Linda Anne DiMeglio, Lauren G. Kanapka, Daniel J. DeSalvo, Barbara J. Anderson, Kara R. Harrington, Marisa E. Hilliard, Lori M. Laffel, William V. Tamborlane, Michelle Anne Van Name, Raj Paul Wadwa et al. · 2020 · Diabetic Medicine
  84. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes
    Tatsuhiko Urakami, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Junichi Suzuki, Ichiro Morioka · 2020 · Endocrine Journal
  85. Long‐term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration
    Claudia Anita Piona, Marco Marigliano, Enza Mozzillo, Adriana Franzese, Angela Zanfardino, Dario Iafusco, Giulio Maltoni, Stefano Zucchini, Maurizio Delvecchio, Claudio Maffeis · 2020 · Pediatric Diabetes
  86. Association of Time in Range levels with Lower Extremity Arterial Disease in patients with type 2 diabetes
    Jinfeng Li, Ya Li, Weiguo Ma, Yishan Liu, Xiaohong Yin, Chuanqing Xie, Jiao Bai, Min Zhang · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  87. Weight Management in Youth with Type 1 Diabetes and Obesity: Challenges and Possible Solutions
    Zaharieva, Dessi P., Addala, Ananta, Simmons, Kimber M., Maahs, David M. · 2020 · Current Obesity Reports
  88. Long-term continuous glucose monitor use in very young children with type 1 diabetes: one-year results from the SENCE study
    Van Name, Michelle A., Kanapka, Lauren G., DiMeglio, Linda A., Miller, Kellee M., Albanese-O’Neill, Anastasia, Commissariat, Persis, Corathers, Sarah D., Harrington, Kara R., Hilliard, Marisa E., Anderson, Barbara J. et al. · 2023 · Journal of Diabetes Science and Technology
  89. Limitations in Achieving Glycemic Targets From CGM Data and Persistence of Severe Hypoglycemia in Adults With Type 1 Diabetes Regardless of Insulin Delivery Method
    Lori M. Laffel, Jennifer L. Sherr, Jingwen Liu, Wendy A. Wolf, Jeoffrey A. Bispham, KATHERINE S.M. CHAPMAN, Daniel A. Finan, Lina Titievsky, Tina Liu, Kaitlin A. Hagan et al. · 2024 · Diabetes Care
  90. Glycaemic control and pregnancy outcomes with real-time continuous glucose monitoring in gestational diabetes (GRACE): an open-label, multicentre, multinational, randomised controlled trial
    Tina Linder, Iris Dressler‐Steinbach, Silke Wegener, Karen Schellong, Saskia Schmidt, Daniel Eppel, Cécile Monod, Florian Heinzl, Katharina Redling, Bettina Felicitas Winzeler et al. · 2025 · The Lancet Diabetes & Endocrinology
  91. Impact of flash glucose monitoring on glucose control and hospitalization in type 1 diabetes: A nationwide cohort study
    Anat Tsur, Avivit Cahn, Meirav Israel, Ilan Feldhamer, Ariel Hammerman, Rena M. Pollack · 2020 · Diabetes/Metabolism Research and Reviews
  92. Factors Related to Improvement of Glycemic Control Among Adults with Type 1 Diabetes During Lockdown Due to COVID-19
    Óscar Moreno Domínguez, Noemí González Pérez de Villar, Beatriz Barquiel, Natalia Hillman, Ruth Gaspar, Montserrat Arévalo-Gómez, Lucrecia Herranz · 2020 · Diabetes Technology & Therapeutics
  93. Association of sleep quality with glycemic variability assessed by flash glucose monitoring in patients with type 2 diabetes
    Yang� Yang, Lihua Zhao, Dandan Li, Feng Xu, Xiaohua Wang, Chunfeng Lu, Chunhua Wang, Chao Yu, Xiulin Zhang, Li-yan Ning et al. · 2021 · Diabetology & Metabolic Syndrome
  94. The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review
    Evanthia Gouveri, Νικόλαος Παπάνας · 2022 · Diabetes Therapy
  95. Decreasing complexity of glucose time series derived from continuous glucose monitoring is correlated with deteriorating glucose regulation
    Cheng Li, Xiaojing Ma, Jingyi Lu, Rui Tao, Xia Yu, Yifei Mo, Wei Lu, Yuqian Bao, Jian Zhou, Weiping Jia · 2022 · Frontiers of Medicine
  96. The best insulin delivery is a human pancreas
    Kasi R. McCune, Nina L. Owen‐Simon, Geoffrey K. Dube, Lloyd E. Ratner · 2023 · Clinical Transplantation
  97. Performance of the Glucose Management Indicator (GMI) in Type 2 Diabetes
    Michael Fang, Dan Wang, Mary R. Rooney, Justin Basile Echouffo-Tcheugui, Josef Coresh, Rashmi Nisha Aurora, Naresh M. Punjabi, Elizabeth Selvin · 2023 · Clinical Chemistry
  98. Layered Meta-Learning Algorithm for Predicting Adverse Events in Type 1 Diabetes
    Federico D’Antoni, Lorenzo Petrosino, Alessandro Marchetti, Luca Bacco, Silvia Pieralice, Luca Vollero, Paolo Pozzilli, Vincenzo Piemonte, Mario Merone · 2023 · IEEE Access
  99. Effects of postprandial exercise on blood glucose levels in adults with type 1 diabetes: a review
    Simon Helleputte, Jane Elizabeth Yardley, Sam N. Scott, Jan Stautemas, Laura Jansseune, Joke Marlier, Tine L.M. De Backer, Bruno Lapauw, Patrick Calders · 2023 · Diabetologia
  100. Uncovering personalized glucose responses and circadian rhythms from multiple wearable biosensors with Bayesian dynamical modeling
    Nick E. Phillips, Tinh‐Hai Collet, Félix Naef · 2023 · Cell Reports Methods